Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 25 Feb 2022 |
2 | Reply to Exam Report (MIS-R) | 07 May 2022 |
3 | Authorization Letter | 07 Jan 2023 |
4 | Journal Copy | 02 Mar 2023 |
5 | TM-O(NOTICE OF OPPOSITION) | 09 May 2023 |
6 | Annexure -1 under rule 46 | 27 May 2024 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 27 May 2024 |
7 | Annexure -1 under rule 46 | 27 May 2024 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 27 May 2024 |
8 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 30 Jul 2024 |
1 | EXAMINATION REPORT | 13313093 | 07 Apr 2022 | |
2 | Hearing Notice (Show Cause) | 14275973 | 31 Oct 2022 | |
3 | Tribunal Accepted Notice for : 5345014 | 14605610 | 5820587 | 09 Jan 2023 |
4 | Opposition Notice | 16568246 | 6347246 | 17 Nov 2023 |
5 | Opposition Counter Statement | 17309808 | 6522253 | 05 Feb 2024 |
As per IP India data the trademark was applied on 25 February 2022.
INTAS PHARMACEUTICALS applied for Daparyl-v.
Listed class of trademark Daparyl-v is 5.
Daparyl-v is on the Opposed stage of the trademark process.
Serial Number provided to trademark application is 5345014
Trademark application was filed by the following attorney agent:
Y. J. Trivedi & Co
The trademark is categorized as WORD.